Literature DB >> 31576356

Is nodal disease burden relevant in patients with renal cell carcinoma and lymph node invasion?

Francisco Rodriguez-Covarrubias1.   

Abstract

Entities:  

Year:  2019        PMID： 31576356      PMCID： PMC6685840          DOI： 10.21037/atm.2019.06.31

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  10 in total

1.  Lymph node density vs. the American Joint Committee on Cancer TNM nodal staging system in node-positive bladder cancer in patients undergoing extended or super-extended pelvic lymphadenectomy.

Authors:  Donghyun Lee; Sangjun Yoo; Dalsan You; Bumsik Hong; Yong Mee Cho; Jun Hyuk Hong; Choung-Soo Kim; Hanjonh Ahn; Jae Y Ro; In Gab Jeong
Journal:  Urol Oncol       Date:  2017-01-27       Impact factor: 3.498

2.  Renal Cell Carcinoma with Isolated Lymph Node Involvement: Long-term Natural History and Predictors of Oncologic Outcomes Following Surgical Resection.

Authors:  Boris Gershman; Daniel M Moreira; R Houston Thompson; Stephen A Boorjian; Christine M Lohse; Brian A Costello; John C Cheville; Bradley C Leibovich
Journal:  Eur Urol       Date:  2017-01-13       Impact factor: 20.096

3.  The impact of lymph node dissection and positive lymph nodes on cancer-specific mortality in contemporary pT2-3 non-metastatic renal cell carcinoma treated with radical nephrectomy.

Authors:  Michele Marchioni; Marco Bandini; Raisa S Pompe; Tristan Martel; Zhe Tian; Shahrokh F Shariat; Anil Kapoor; Luca Cindolo; Alberto Briganti; Luigi Schips; Umberto Capitanio; Pierre I Karakiewicz
Journal:  BJU Int       Date:  2017-10-12       Impact factor: 5.588

4.  Impact of lymph node dissection at the time of radical nephrectomy with tumor thrombectomy on oncological outcomes: Results from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC).

Authors:  Derya Tilki; Thenappan Chandrasekar; Umberto Capitanio; Gaetano Ciancio; Siamak Daneshmand; Paolo Gontero; Javier Gonzalez; Axel Haferkamp; Markus Hohenfellner; William C Huang; Estefania Linares Espinós; Adam Lorentz; Juan I Martinez-Salamanca; Viraj A Master; James M McKiernan; Francesco Montorsi; Giacomo Novara; Sascha Pahernik; Juan Palou; Raj S Pruthi; Oscar Rodriguez-Faba; Paul Russo; Douglas S Scherr; Shahrokh F Shariat; Martin Spahn; Carlo Terrone; Cesar Vera-Donoso; Richard Zigeuner; John A Libertino; Christopher P Evans
Journal:  Urol Oncol       Date:  2017-11-10       Impact factor: 3.498

5.  Node-positive renal cell carcinoma in the absence of distant metastases: predictors of cancer-specific mortality in a population-based cohort.

Authors:  Quoc-Dien Trinh; Jan Schmitges; Marco Bianchi; Maxine Sun; Shahrokh F Shariat; Jesse Sammon; Claudio Jeldres; Kevin Zorn; Shyam Sukumar; Paul Perrotte; Markus Graefen; Craig G Rogers; James O Peabody; Mani Menon; Pierre I Karakiewicz
Journal:  BJU Int       Date:  2011-11-01       Impact factor: 5.588

6.  The prognostic significance of nodal disease burden in patients with lymph node metastases from renal cell carcinoma.

Authors:  Piotr Zareba; Paul Russo
Journal:  Urol Oncol       Date:  2019-02-28       Impact factor: 3.498

7.  Impact of lymph node invasion and sarcomatoid differentiation on the survival of patients with locally advanced renal cell carcinoma.

Authors:  Francisco Rodríguez-Covarrubias; Ricardo Castillejos-Molina; Mariano Sotomayor; Carlos E Méndez-Probst; Martha Olivia Gómez-Alvarado; Norma Uribe-Uribe; Fernando Gabilondo; Guillermo Feria-Bernal
Journal:  Urol Int       Date:  2010-07-26       Impact factor: 2.089

8.  Retroperitoneal Lymphadenectomy for High Risk, Nonmetastatic Renal Cell Carcinoma: An Analysis of the ASSURE (ECOG-ACRIN 2805) Adjuvant Trial.

Authors:  Benjamin T Ristau; Judi Manola; Naomi B Haas; Daniel Y C Heng; Edward M Messing; Christopher G Wood; Christopher J Kane; Robert S DiPaola; Robert G Uzzo
Journal:  J Urol       Date:  2017-07-18       Impact factor: 7.450

9.  Renal cell carcinoma and pathologic nodal disease: Implications for American Joint Committee on Cancer staging.

Authors:  Kai-Jie Yu; Sarp K Keskin; Matthew A Meissner; Firas G Petros; Xuemei Wang; Leonardo D Borregales; Cindy Gu; Pheroze Tamboli; Surena F Matin; Christopher G Wood; Jose A Karam
Journal:  Cancer       Date:  2018-10-01       Impact factor: 6.860

10.  Radical nephrectomy with and without lymph-node dissection: final results of European Organization for Research and Treatment of Cancer (EORTC) randomized phase 3 trial 30881.

Authors:  Jan H M Blom; Hein van Poppel; Jean M Maréchal; Didier Jacqmin; Fritz H Schröder; Linda de Prijck; Richard Sylvester
Journal:  Eur Urol       Date:  2008-10-01       Impact factor: 20.096
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.